Health insurance benefits of Kadcyla Inj 100mg & 160mg will be registered

Published: 2017-08-07 16:29:00
Updated: 2017-08-07 13:17:12

The health insurance benefits of ‘Kadcyla Inj(trastuzumab emtansine),’ a Roche Korea’s treatment for breast cancer, will be applied today.

The Ministry of Health and Welfare(Minister Neung-Hoo Park) amended and issued the ‘Drug Insurance Benefits List and Upper Limit Price Table’ on the 2nd.



- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email:

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.